Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
81
Employees81
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
81
Employees81

TNXP Key Statistics

Market cap
178.14M
Market cap178.14M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
362.94K
Average volume362.94K
High today
$14.30
High today$14.30
Low today
$13.53
Low today$13.53
Open price
$13.64
Open price$13.64
Volume
379.89K
Volume379.89K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$6.76
52 Week low$6.76

Stock Snapshot

The current Tonix Pharmaceuticals(TNXP) stock price is $14.13, with a market capitalization of 178.14M. The stock trades at a price-to-earnings (P/E) ratio of -0.01.

On 2026-03-04, Tonix Pharmaceuticals(TNXP) stock moved within a range of $13.53 to $14.30. With shares now at $14.13, the stock is trading +4.4% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 379.89K, compared to an average daily volume of 362.94K.

Over the past 52 weeks, Tonix Pharmaceuticals(TNXP) stock has traded between a high of $69.97 and a low of $6.76.

Over the past 52 weeks, Tonix Pharmaceuticals(TNXP) stock has traded between a high of $69.97 and a low of $6.76.

TNXP News

Benzinga 18h
Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting

Tonix Pharmaceuticals Inc. (NASDAQ:TNXP) shares are down during Tuesday’s premarket session following the company’s recent uplisting to the Nasdaq Global Select...

Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting
TipRanks 18h
Tonix Pharma Uplists to Nasdaq Global Select Market

Tonix Pharma ( (TNXP) ) has provided an announcement. On March 3, 2026, Tonix Pharmaceuticals announced that Nasdaq approved the transfer of its common stock l...

TipRanks 18h
Tonix Pharmaceuticals approved to list on Nasdaq Global Select Market

Tonix Pharmaceuticals (TNXP) announced that it has received approval from Nasdaq to transfer the listing of its common stock from the Nasdaq Capital Market to t...

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.